EPILEPSY THAT DOES NOT RESPOND TO MEDICINES. WHEN SURGERY BECOMES THE BEST MEDICAL DECISION

Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.
WJFW

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients ...